Jefferies Financial Group Inc. Teva Pharmaceutical Industries LTD Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $271,575 - $369,749	21,250 New	21,250 $345,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $111,765 - $147,002	15,523 Added 1546.12%	16,527 $124,000
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $1.74 Million - $2.37 Million	-208,470 Reduced 99.52%	1,004 $8,000
Q4 2022 Sep 21, 2023	BUY	$7.95 - $9.48 $1.53 Million - $1.83 Million	192,947 Added 1167.47%	209,474 $1.91 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $1.67 Million - $1.99 Million	209,474 New	209,474 $1.91 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.